APOE and Cognitive impairment: In the current study, we aimed to assess the plasma apoE levels (total and isoform levels) in a cohort of older B/AA and NHW participants with normal cognition, mild cognitive impairment (MCI), or mild AD dementia with detailed neuropsychological, CSF, and magnetic resonance imaging (MRI) analysis [33].